Susan Hasty, Publisher
Table of Contents . . . May 22nd, 2000
Non-Subscriber - Summaries OnlyRelated Areas: Other Issues in Hepatitis Weekly | Other Publications
TT Virus - Genome Differences Suggest Genetic Complexity of Virus
Amprenavir - Liver Dysfunction in HIV Patients Decreases Drug Metabolism Rate
Immunology - Antibodies to HAV Decrease after Liver Transplantation
Prognostics - Genetic Factors Predict Progression to Chronic Liver Disease
Therapy - VX-497 Combination Therapy More Potent than Ribavirin Combined Therapy
Therapy (HCV) - Serum Biochemical Indicators Reflect Response to Interferon (alpha)
Vaccine Safety - Blood Mercury Levels Higher in Preterm Infants Receiving Hepatitis B Vaccine
Epidemiology - Investigators Study Death Trends in Patients with Hepatitis and HIV
Epidemiology - The Makings of a Public Health Epidemic: Drug Abuse, HIV/AIDS, and Hepatitis C
Drug Development - New Trends Predicted in Treating Hepatitis C Virus Infection
Industry News - Legal Action Initiated for Patent Infringement of Phase III Hepatitis Treatment
Organ Donation - Man Donates Portion of Liver to Random Recipient
Pediatrics - Alaska Proposes Boosting Number of Immunizations for Children
Therapy (HCV) - Anti-Hepatitis C Ribozyme Clinical Trials Completed
Therapy (HCV) - Combination Therapy for Hepatitis C Launched in Spain
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.